OpenAI acquires drug R&D collaboration platform Orchestra Bio

PANews October 21 news, according to an official OpenAI announcement, OpenAI has acquired Orchestra Bio, a drug R&D collaboration platform. The platform helps biopharmaceutical teams coordinate complex drug development processes, allowing scientists and project leads to delegate the monitoring and tracking of research and trials to AI agents. OpenAI stated that it will integrate Orchestra's team and technology with Rosalind, its life sciences research AI model and tool, to help new therapies reach patients faster.

Labarai masu alaƙa

11-02 03:02 UTC
Financing Weekly | Kalshi completes $1 billion Series G funding, led by Sequoia Capital and Wellington Management.
Kalshi completed a $1 billion Series G funding round, reaching a post-money valuation of $40 billion, nearly double its $22 billion valuation in May this year;...
11-02 02:59 UTC
Dandalin cinikin hannun jari na kan sarkar StableStock ya kammala sabon zagayen tallafin kuɗi na dabarun kasuwanci a ƙimar dala miliyan 75, tare da halartar Amber da wasu.
11-02 02:40 UTC
RoboScience Machine Science ya kammala kuɗaɗen miliyoyin yuan a cikin tallafin Series A2.
11-01 05:14 UTC
An rage maƙasudin tara kuɗi na OpenAI da dala biliyan 10: Shin labarin “kona kuɗi” na AI yana raguwa?
10-31 09:53 UTC
Rates Exchange, wata musayar ciniki da kariya ta riba a kan sarkar, ta sami jari daga Coinbase Ventures.

Financing Weekly | Kalshi completes $1 billion Series G funding, led by Sequoia Capital and Wellington Management.

Dandalin cinikin hannun jari na kan sarkar StableStock ya kammala sabon zagayen tallafin kuɗi na dabarun kasuwanci a ƙimar dala miliyan 75, tare da halartar Amber da wasu.

RoboScience Machine Science ya kammala kuɗaɗen miliyoyin yuan a cikin tallafin Series A2.

An rage maƙasudin tara kuɗi na OpenAI da dala biliyan 10: Shin labarin “kona kuɗi” na AI yana raguwa?

Rates Exchange, wata musayar ciniki da kariya ta riba a kan sarkar, ta sami jari daga Coinbase Ventures.